Delta Health

Delta Health is a private international healthcare company focused on clinical drug development support, proprietary clinical trial investigative sites, international telemedicine, and advanced medical solutions. The company describes itself as a healthcare conglomerate operating across medical innovation, site management, telemedicine, and affiliated medical services. Its public materials emphasize late-stage FDA-compliant development capabilities, especially Phase 2 and Phase 3 clinical programs for drugs, biologics, vaccines, and medical devices. Delta Health also highlights collaborations tied to oncology imaging, RNA-based anticoagulation therapy, androgen inhibition in prostate cancer, and cross-border healthcare initiatives with government and hospital partners. Overall, it appears to function more as a clinical development and healthcare-services organization than as a traditional single-asset biotech sponsor.